title: Effects of alpha(1)-adrenoceptor antagonists on male sexual function.
abstract: alpha(1)-Adrenoceptor antagonists such as alfuzosin, doxazosin, tamsulosin and terazosin are first-line agents for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH), but are only second-line agents (doxazosin and terazosin only) for the treatment of arterial hypertension. Sexual function is complex and includes multiple domains such as sexual desire (libido), erectile function and ejaculatory function. Erectile and ejaculatory functions are frequently reduced in patients with BPH and can impact on their quality of life. Therefore, the treatment of BPH should aim to maintain or even restore sexual function.alpha(1)-Adrenoceptor antagonists lack major effects on sexual desire in placebo-controlled studies. Reports on erectile function are inconsistent, with both beneficial and adverse effects being reported, but impotence can occur in some patients without clear differences between drugs. Ejaculatory dysfunction during treatment may represent (relative) an ejaculation. It occurs more frequently with tamsulosin than with other drugs of this class, but the differences are not big enough to be consistently detectable in directly comparative studies. We propose that such differences between drugs should be weighed against differences in cardiovascular tolerability when choosing the optimal treatment for each patient.
authors.affiliation: Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
authors.forename: Marleen M
authors.initials: MM
authors.lastname: van Dijk
authors.forename: Jean J M C H
authors.initials: JJ
authors.lastname: de la Rosette
authors.forename: Martin C
authors.initials: MC
authors.lastname: Michel
mesh_terms: D018674:Adrenergic Antagonists / Q000009:adverse effects / Q000494:pharmacology*; D058668:Adrenergic alpha-1 Receptor Antagonists; D000328:Adult; D000368:Aged; D017292:Doxazosin / Q000009:adverse effects / Q000494:pharmacology; D004542:Ejaculation / Q000187:drug effects*; D007172:Erectile Dysfunction / Q000209:etiology; D006801:Humans; D007989:Libido / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D010410:Penile Erection / Q000187:drug effects*; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000378:metabolism; D011799:Quinazolines / Q000009:adverse effects / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic; D018340:Receptors, Adrenergic, alpha-1 / Q000378:metabolism; D013449:Sulfonamides / Q000009:adverse effects / Q000494:pharmacology; D000077409:Tamsulosin
chemical_list: D018674:Adrenergic Antagonists; D058668:Adrenergic alpha-1 Receptor Antagonists; D011799:Quinazolines; D018340:Receptors, Adrenergic, alpha-1; D013449:Sulfonamides; C047638:alfuzosin; D000077409:Tamsulosin; D017292:Doxazosin